Treatment Action Group releases policy brief on US investments in tuberculosis research and development: A policy brief released by TAG today argues that decreasing US investment in TB research adds to the public health threat posed by TB to the United States and has already stalled the development of better and faster-acting treatment. Thanks to stagnant […]
The following is a guest post by Madhukar Pai of the McGill International TB Centre, Prashant Yadav of Montreal & Stephen M. Ross School of Business, and Ravi Anupindi of the University of Michigan, Ann Arbor. Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis […]
HIV
Oct. 7, 2017 SAN DIEGO – Dr. Edsel Salvaña has two posters in the exhibit hall here, each one carrying terrible news from the Philippines, that, […]
Tuberculosis
GUADALAJARA, Mexico – For all the emphasis on new tuberculosis treatments and repurposed drugs to meet the World Health Organization’s End TB goals at the Union […]
Research & Development
Report gives evidence that neurological impacts of Zika go beyond effects on brain development By the time pediatric pathologists explored the cases reported in the August […]
Policy
Projections based on current burdens of disease, along with data from the preceding 26 years, show both vast inequalities of progress, as well as the likelihood […]